Journals / Eurasian Journal of Medical Investigation / 2022 / Cilt: 6 - Sayı: 1

Predictive Importance of Ultrasonography and Anti-Thyroid Antibodies in the Management of Thyroid Nodules in Indeterminate Cytology

Pages
122–127
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In the management of thyroid nodules in indeterminate cytology, suspicious ultrasonographic features and Hashimoto's thyroiditis should be encouraging in making the surgical decision.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study is to examine the effects of ultrasonography and serum anti-thyroid antibody (ATAb)levels in predicting malignancy in cases where molecular tests cannot be performed in indeterminate thyroid nodules.
📊
Key Findings & Data:Methods: Ultrasonographic features of the dominant thyroid nodule of a total of 228 patients who were operated for nodular goiter were analyzed and preoperative serum ATAb levels were examined.
💡
Conclusion & Impact:Conclusion: In the management of thyroid nodules in indeterminate cytology, suspicious ultrasonographic features and Hashimoto's thyroiditis should be encouraging in making the surgical decision.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study is to examine the effects of ultrasonography and serum anti-thyroid antibody (ATAb)levels in predicting malignancy in cases where molecular tests cannot be performed in indeterminate thyroid nodules. Methods: Ultrasonographic features of the dominant thyroid nodule of a total of 228 patients who were operated for nodular goiter were analyzed and preoperative serum ATAb levels were examined. Especially in Bethesda category 3 nodules correlation of these parameters with malignancy rates and Hashimoto’s thyroiditis (HT) was investigated. Results: Malignancy was detected in 24.5% (12/49) Bethesda Category 3 nodules. Anti-thyroglobulin (Anti-TG) and-or anti-thyroid peroxidase (anti-TPO) positivity in serum 36.5% (72/197) was correlated with histopathologically proven HT (p=0.001). Poor prognostic factors were found to be less common in HT-associated papillary thyroid cancer (PTC). Ultrasonographic characteristics such as hypoechogenicity, microcalcification, and border irregularity were significant in predicting malignancy in indeterminate nodules (p=0.038- 0.003- 0.004, respectively). The central vascularization pattern remained in the background compared to other parameters (p=0.059). In the presence of ultrasonographic halo, 92.7% (51/55) of the nodules were benign (p=0.001). Conclusion: In the management of thyroid nodules in indeterminate cytology, suspicious ultrasonographic features and Hashimoto's thyroiditis should be encouraging in making the surgical decision.

🔖

Cite This Article

BENEK, S., PEDUK, Ş. (2022). Predictive Importance of Ultrasonography and Anti-Thyroid Antibodies in the Management of Thyroid Nodules in Indeterminate Cytology. Eurasian Journal of Medical Investigation, Cilt: 6 - Sayı: 1, 122–127. https://ajindex.com/articles/508531

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ito Y, Miyauchi A, Kudo T, Oda H, Yamamoto M, Sasai H, et al. Trends in the ımplementation of active surveillance for lowrisk papillary thyroid microcarcinomas at kuma hospital: gradual ıncrease and heterogeneity in the acceptance of this new management option. Thyroid 2018;28:488–95
  2. Cibas ES, Ali SZ. The bethesda system for reporting thyroid cytopathology. Thyroid 2009;19:1159–65
  3. Tagoe CE, Sheth T, Golub E, Sorensen K. Rheumatic associations of autoimmune thyroid disease: a systematic review. Clin Rheumatol 2019;38:1801–9
  4. Ohye H, Fukata S, Kubota S, Sasaki I, Takamura Y, Matsuzuka F, et al. Successful treatment for recurrent painful Hashimoto's thyroiditis by total thyroidectomy. Thyroid 2005;15:340–5
  5. Joseph CG, Darrah E, Shah A, Skora AD, Casciola-Rosen LA, Wigley FM, et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 2014;343:152–7
  6. Azizi G, Keller JM, Lewis M, Piper K, Puett D, Rivenbark KM, et.al. Association of Hashimoto's thyroiditis with thyroid cancer. Endocr Relat Cancer 2014;21:845–52
  7. Galdiero MR, Varricchi G, Marone G. The immune network in thyroid cancer. Oncoimmunology 2016;5:e1168556
  8. Noureldine SI, Tufano RP. Association of Hashimoto's thyroiditis and thyroid cancer. Curr Opin Oncol 2015;27:21–5
  9. Mulder MB, Khazeni KC, Sussman MS, Lew JB, Farra JC. Chronic lymphocytic thyroiditis may lower accuracy of AUS/FLUS cytopathology in surgical patients. J Surg Res 2020;245:244–8
  10. Topaloglu O, Baser H, Cuhaci FN, Sungu N,Yalcin A,Ersoy R. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology. Endocrine 2016;54:156–68
  11. Saygılı ES, Özgüven BY, Öztürk FY, Oğuzsoy T, Çakır SD, Basmaz SE, et al. Is only Thyroid Peroxidase Antibody Sufficient for Diagnosing Chronic Lymphocytic Thyroiditis? Sisli Etfal Hastan Tip Bul 2018;52:97–102
  12. Caturegli P, Remigis AD, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 2014;13:391–7
  13. Jeong SH, Hong HS, Lee EH, Kwak JJ. Papillary thyroid carcinoma arising in children and adolescent Hashimoto's thyroiditis: ultrasonographic and pathologic findings. Int J Endocrinol 2016;2016:2397690
  14. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma